Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 8.30 is 23% above its 1-year average of 6.77, near the high end of its 1-year range (2.85–9.17).
As of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 8.30.
QUICK RATIO (ACID-TEST)
8.30
QUICK RATIO (ACID-TEST) AVG TTM
N/A
QUICK RATIO (ACID-TEST) AVG 3Y
N/A
QUICK RATIO (ACID-TEST) AVG 5Y
N/A
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 871 covered companies
CURRENT VS SECTOR MEDIAN
+147.85%
vs the sector median at left
Generate Biomedicines, Inc.
Market Cap
$1.77B
Quick Ratio (Acid-Test)
8.30
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.75B
Quick Ratio (Acid-Test)
1.78
TTM Avg
1.68
3Y Avg
1.66
5Y Avg
1.61
Market Cap
$1.74B
Quick Ratio (Acid-Test)
10.63
TTM Avg
5.62
3Y Avg
5.25
5Y Avg
6.00
Market Cap
$1.74B
Quick Ratio (Acid-Test)
1.02
TTM Avg
1.38
3Y Avg
1.55
5Y Avg
2.14
Market Cap
$1.74B
Quick Ratio (Acid-Test)
1.70
TTM Avg
1.79
3Y Avg
1.95
5Y Avg
2.14
Market Cap
$1.81B
Quick Ratio (Acid-Test)
13.96
TTM Avg
11.13
3Y Avg
7.91
5Y Avg
6.39
Market Cap
$1.73B
Quick Ratio (Acid-Test)
6.65
TTM Avg
5.42
3Y Avg
7.28
5Y Avg
7.47
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Generate Biomedicines, Inc. (GENB) | $1.77B | 8.30 | N/A | N/A | N/A |
| Surgery Partners, Inc. (SGRY)vs › | $1.75B | 1.78 | 1.68 | 1.66 | 1.61 |
| Novocure Ltd (NVCR)vs › | $1.74B | 2.70 | 2.06 | 4.13 | 5.41 |
| Absci Corporation (ABSI)vs › | $1.74B | 10.63 | 5.62 | 5.25 | 6.00 |
| Xeris Biopharma Holdings, Inc. (XERS)vs › | $1.74B | 1.02 | 1.38 | 1.55 | 2.14 |
| Alignment Healthcare, Inc. (ALHC)vs › | $1.74B | 1.70 | 1.79 | 1.95 | 2.14 |
| Xencor, Inc. (XNCR)vs › | $1.81B | 6.39 | 6.43 | 7.70 | 7.01 |
| LeMaitre Vascular, Inc. (LMAT)vs › | $1.81B | 13.96 | 11.13 | 7.91 | 6.39 |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.73B | 6.65 | 5.42 | 7.28 | 7.47 |
| Azenta, Inc. (AZTA)vs › | $1.81B | 2.21 | 3.08 | 5.65 | 4.53 |
Quick Ratio
8.30
Excludes inventory
Current Ratio
8.30
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 8.30 |
| 2026-03-31 | 9.17 |
| 2025-12-31 | 2.85 |
